EPA Approvals of BioShield's Core Active Ingredients Open New Market Opportunities; Sales Increase 200% for the Fiscal Quarter Ended Dec. 31, 1998.

NORCROSS, Ga.--(BUSINESS WIRE)--Dec. 7, 1998--Timothy C. Moses, co-chairman, president & CEO of BioShield Technologies, Inc. (Nasdaq:BSTIU) stated today that the company's recently announced EPA (Environmental Protection Administration) registration approvals of two of its core-active products, the AM500 and 500I, opens the potential for multi-million dollar market opportunities for BioShield to sell its products.

Moses said, "Receiving these approvals represents a major milestone for us, in that it allows the Company to better compete in a variety of market segments including the medical, retail, industrial, institutional and OEM markets. We believe that theses market segments together represent a $1.4 billion dollar industry."

Moses added, "Since receiving EPA approvals, our sales have already increased approximately 200% for the fiscal quarter ending Dec. 31, 1998 compared to the prior year's fiscal quarter."

AM500 and 500I provide residual inhibition of microorganisms responsible for odor, deterioration, and discoloration. The long list of EPA approved uses and articles includes such common articles as socks, shower curtains, and toilet seat covers. BioShield AM500 is an end-use product containing 5% of the active ingredient in water. The active ingredient is capable of bonding to surfaces and is further diluted with water before application.

BioShield AM500I is for manufacturing use only and contains 5% of the same active ingredient. This product can be used by manufacturers to reduce deterioration of their products by microorganisms.

BioShield Technologies, Inc. develops and markets antimicrobial and biostatic products for retail sale and for use in the industrial, environmental, and medical markets. BioShield's proprietary molecule is effective against a wide variety of microbes offering a more broad based killing power than standard antibacterial technologies.

Antimicrobials not only kill bacteria on contact but also kill a variety of viruses, fungi, algae, yeast and other microbes. BioShield's molecule covalently bonds to surfaces, providing residual killing power long after the original application and is non-toxic, non-flammable and environmentally friendly.

Statements in this press release that are not historical are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including, but not limited to, risks and uncertainties related to new developing technologies, dependence on collaborative partners, the inherent complexity and uncertainty regarding the development of products, BioShield's early-stage development, the result of research and development efforts, future capital needs, and the uncertainty of additional funding and government regulations and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof.